explains dendritic cells filled peptides tumor hope rna proteins tumor help dendritic cells stimulate immune system attack cancer arlen group testing phase trial monoclonal antibody treat patients common form pancreatic cancer preliminary data antibody finds target 50 60 percent patients adenocarcinoma says not mean leave disease free hopes combination new approaches standard drugs yield better results trial plan start year think far early treatment diseases saltz concludes endocrine cancer variety jobs treated different variety chemotherapy drugs new drugs type approved u.s. food drug administration fda earlier year everolimus sold afinitor works blocking mtor kinase target alter cellular signaling approved May